TABLE 3.

Sensitivity, Specificity, PPV, and NPV Scores for Patients With MEN1 and Non-MEN1 Syndrome-related Parathyroid Tumors

	Aberrant tumors per patient (n)	Sensitivity (95% CI)	Specificity (95% CI)	PPV (95% CI)	NPV (95% CI)
All tumors	1	100 (79-100)	91 (75-98)	84 (60-97)	100 (88-100)
Single tumors	1	100 (63-100)	100 (81-100)	100 (63-100)	100 (81-100)
Multiple tumors	1	100 (63-100)	79 (49-95)	73 (39-94)	100 (72-100)
	2	100 (63-100)	100 (77-100)	100 (63-100)	100 (77-100)
	3	100 (48-100)	100 (66-100)	100 (48-100)	100 (66-100)